Genetic variation in the antigen-presenting lectin-like receptor gene complex (APLEC) associates with autoimmunity and arthritis in rats and humans. We hypothesized that the encoded C-type lectin-like receptors might influence innate immunity and responses to infectious agents. To test this hypothesis, we compared in vivo and in vitro phenotypes in DA rats and APLEC-congenic rats. Survival rates following infection with Staphylococcus aureus and Herpes simplex virus differed significantly between the two strains. Likewise, differential delayed type hypersensitivity (DTH), an immunological reaction involving T lymphocytes and macrophages, was observed in response to provocation with the chemical oxazolone. Unstimulated bone marrow-derived macrophages from the two strains appeared to already have polarized activation states with different mRNA levels of CD163 and Dectin-1 receptors. Following stimulation with a panel of microbial agents, differences in induced mRNA and protein levels were shown for interleukin (IL)-6 and IL-10 following stimulation with lipopolysaccharide, mannan and b-glucan. Expression levels of APLEC gene mRNAs also differed, and both strains had a notably dichotomous expression of the genes, with general downregulation of all four Dcir genes and upregulation of Mincle and Mcl. We suggest that human APLEC genes may similarly regulate infectious diseases, DTH and general macrophage activation status.
Introduction
The innate immune system is crucial in defending the host against a range of microbial challenges, and leukocytes are important mediators of this defense, with macrophages having a particularly prominent role. Despite this, infectious diseases are often fatal in humans, [1] [2] [3] and include Herpes simplex virus (HSV)-encephalitis, which is the most common cause of acute viral encephalitis in the western world, and Staphylococcus aureus, which is a common cause of sepsis and the most common cause of septic arthritis characterized by severe joint destruction and high mortality. Animal models for these two infectious diseases have been developed to delineate their pathogeneses, 3, 4 and to help develop preventive and therapeutic strategies. Although rarely used for the purpose, infectious disease models also allow for genetic investigations to identify genetic risk factors.
We recently identified a gene cluster designated the antigen-presenting lectin-like receptor gene complex (APLEC), which regulates autoimmunity and several models of rheumatoid arthritis. 5, 6 The cluster contains seven genes encoding C-type lectin-like receptors, that is, Mincle, Mcl, Dcar1 and Dcir1-Dcir4, which are expressed on leukocytes, to some extent on T lymphocytes, 7 but mainly on neutrophils and antigen-presenting cells, including macrophages. [5] [6] [7] The ligands and functions of the receptors remain unknown, but the receptor type has been implicated in diverse functions, such as microbial pattern recognition, cellular adhesion and migration, antigen uptake and presentation, T cell co-stimulation, and signal transduction through immunoreceptor tyrosine-based inhibitory or activating motifs (ITIMs and ITAMs, respectively). [8] [9] [10] [11] Interestingly, we observed earlier that APLEC regulates clinical phenotypes in RA models induced by nonimmunogenic structures that activate the innate immune system, for example, incomplete Freund's adjuvant oil and yeast b-glucan. 5 Herein, we tested the hypothesis that APLEC might also regulate infectious diseases and innate macrophage reactivity. We thus compared inbred DA rats with congenic DA rats (R17) that carry APLEC (o0.6 Mb substitution) derived from inbred PVG.1AV1 rats. 5, 6 The phenotypes evaluated in DA and R17 rats were (i) S. aureus-induced septic arthritis; (ii) HSVinduced encephalitis; (iii) oxazalone-induced delayed type hypersensitivity (DTH) as well as olive oil-induced inflammation; and (iv) cellular responses of bone marrow (BM)-derived macrophages (BMMF) to different types of microbial adjuvants. We report a distinct genetic influence of APLEC on most of these phenotypes relating to innate immunity.
Results

APLEC influences clinical outcome of S. aureus infection
We first determined the effect of APLEC on S. aureusinduced sepsis and arthritis. Surviving rats were killed on day 15 following S. aureus inoculation. At this time point, R17 rats displayed a higher mortality compared with DA rats owing to bacterial sepsis (survival: 5/18 vs 14/18, P ¼ 0.002) ( Figure 1a shows survival rate over time). Concerning septic arthritis, R17 rats had a later onset (day of onset: 7.1 ± 2.6 vs 4.8 ± 2.3, P ¼ 0.03).
Unfortunately, further analysis of other clinical phenotypes, for example, arthritis severity and incidence, was hindered by limited data concerning R17 rats owing to early mortality.
APLEC influences clinical outcome of HSV infection
We next determined the effect of APLEC on HSV-induced encephalitis. Rats were killed upon first definitive symptoms of neurological malfunction, and clinically unaffected rats were killed on day 10 following viral inoculation. At this time point, R17 rats displayed lower mortality compared with DA rats (survival: 5/12 vs 0/12, P ¼ 0.018) (Figure 1b shows survival rate over time). It is noted that the survival of R17 was not due to resistance against infection or lack of inflammation. Immunohistochemical analysis of brain tissues revealed staining in both DA and R17 of HSV-1 protein and markers of leukocyte infiltration, that is the macrophage marker ED1, and the lymphocyte markers CD8 and CD3. There was even a tendency to more positive staining in R17 rats (data not included). Figure 2 exemplifies the abundance of HSV and inflammatory cells in a clinically unaffected R17 rat that was killed at the end of the experiment.
APLEC influences cell-mediated inflammatory responses in vivo As a first step toward identifying individual cell types that mediate the effects of APLEC, we investigated two models of in vivo cell-mediated inflammatory responses. There was no difference between the two strains in response to olive oil injected into the footpads (0.85±0.28 vs 0.81 ± 0.43), an inflammatory reaction that is mediated by granulocytes and that is independent of T cells. 12 In contrast, the DTH reaction to oxazolone, a T-cell-and macrophage-dependent skin swelling inflammatory response, 13 was decreased in R17 rats compared with in DA rats (0.31 ± 0.03 vs 0.37 ± 0.02, P ¼ 0.038) (Figure 1c) . Our results implicate macrophages and/or T cells as important mediators of APLEC effects. We decided to focus on macrophages as they express APLEC-encoded receptors and exert important roles in both adaptive and innate immunity.
APLEC influences BMMF activation in vitro We next determined whether the observed differences between DA and R17 rats in response to infectious diseases and DTH reaction could be related to differential activation of MF. Arginine is a common substrate for both arginase and nitric oxide (NO) synthase, the former leading to production of ornithine and the latter converting arginine to NO. The balance of NO/arginase activity is mutually regulated 14 and has been associated with 'classic' or 'alternative' MF activation. 15, 16 Accordingly, we measured arginase activity and NO production in BMMF following activation with lipopolysaccharide (LPS) alone or LPS and interferon (IFN)-g in combination. Secretion of NO did not differ between R17 and DA MF (Figure 3b ), but there was indeed a lower arginase activity in R17 rat MF compared with DA (1.01±0.38 vs 1.39 ± 0.46, P ¼ 0.024) (Figure 3a) , suggesting differential MF activation. APLEC influences innate immune cytokine production We then determined whether differential MF activation could be shown concerning cytokine production induced by a variety of microbial stimulants of the innate immune system. First, cytokine mRNA levels following 6 h culture were measured by real-time PCR, targets were the classical proinflammatory cytokines tumor necrosis factor-a and IL-1b, the typically anti-inflammatory cytokines IL-10 and transforming growth factor-b, and the pleiotropic cytokine IL-6. [17] [18] [19] [20] In addition, we targeted p19, a subunit for IL-23 related to Th17 response, and two gene products related to the Th1 response, that is IFNg and p35, a subunit for IL-12. However, data for these latter targets are not included as there were no expression differences between DA and R17 rats (p19 and p35) or because the target was almost undetectable (IFNg). Under culture conditions, without addition of stimulants, there were no differences in measured cytokine mRNAs between R17 and DA rats (Figure 4 ). Following stimulation with various molecules, the cytokine mRNAs were generally upregulated in both strains, except IL-6, which remained unchanged in response to mannan and PGN but which was downregulated in response to MDP and CpG. Concerning IL-6 expression, mRNA expression was lower in R17 compared with DA following stimulation with b-glucan, zymosan and LPS. In contrast, mRNA levels for IL-1b and IL-10 were consistently upregulated, and more so in R17 than in DA cells, except following stimulation with CpG DNA (Figure 4) . Second, cytokine protein levels following 18 h culture were measured by enzyme-linked immunosorbent assays specific for IL-1b, IL-6 and IL-10, respectively. For IL-1b, no secreted protein could be detected under any culture conditions. Without the addition of stimulants, there were no differences in IL-6 and IL-10 protein levels between cells from R17 and DA rats ( Figure 5 ). Stimulation with the various microbial adjuvants upregulated cytokine production, except that CpG did not upregulate IL-10, and that MDP did not upregulate IL-6 and IL-10 (data not included). Strain differences were apparent following stimulation with b-glucan, mannan and LPS, with MF from R17 secreting higher IL-6 and IL-10 protein levels than MF from DA ( Figure 5 ). Altogether, these data show that APLEC influences levels of cytokine mRNA and protein following in vitro stimulation in MF.
The expression pattern of APLEC genes is stimulation dependent
We then addressed how the observed differential BMMF activation related to expression levels of APLEC genes. We analyzed mRNA only, as there are presently no antibodies available for protein analyses. During these experiments, we discovered in both strains an almost complete loss of Dcar1 mRNA expression already a few hours after cells were taken from BM into culture (data not included). For the other APLEC genes, the transcript levels already differed before stimulation for Dcir4, Dcir1, Mcl and Mincle, with markedly lower mRNA levels in MF derived from R17 compared with DA. Following stimulation, a notably dichotomous expression of the APLEC genes was evident, with a generally opposite regulation of the four Dcir genes compared with Mincle and Mcl. Compared with levels in unstimulated MF, the relative up-or downregulation of transcript levels was generally more pronounced in R17 cells than in DA cells ( Figure 6 ).
APLEC affects expression of other innate immune receptors
That MF from R17 and DA responded differently to microbial adjuvants, and that this was linked to differential mRNA levels for the APLEC-encoded receptors suggested inherent polarization of the MF. We therefore determined whether APLEC influences mRNA levels of other innate receptors ( Figure 7 ). Levels of mRNA were similar in MF from R17 and DA for TLR4 (a receptor for LPS) and for TLR2 (a -glucan receptor). 21 In contrast, mRNA levels were higher in R17 MF for Dectin-1 (a b-glucan receptor) and for CD163 (a scavenger receptor for hemoglobin-haptoglobin complexes). 22 Thus, APLEC indeed influences MF mRNA levels of other innate immunity receptors.
Discussion
Rat APLEC was recently identified as a genetic determinant of different forms of immune-mediated arthritis, and with a quantitative and qualitative impact on the adaptive autoimmune response in collagen-induced arthritis. 5 Although the tested rheumatoid arthritis models depend on lymphocytes, they also rely on the use of injected adjuvant to break self-tolerance.
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No stimulation TLR2 TLR4 Dectin-1 CD163 Figure 7 Levels of mRNA for non-APLEC receptors in cultured bone marrow-derived macrophages from R17 and DA rats. The data were generated from two independent experiments, and total RNA was isolated from unstimulated cells at 6 h (n ¼ 8/group from each experiment) and remained the same as the control for Figure 4 and Figure 6 . The mRNA expression level is determined by real-time quantitative PCR. Data are presented as mean ± s.d. **Po0.01.
Consequently, the impact of APLEC on adaptive immunity in arthritis could be mediated by innate immune mechanisms exerted for example by MF responding to adjuvants. Herein, we show that APLEC indeed influences functional responses of MF to a variety of microbial adjuvants, and that the gene complex regulates MF-mediated DTH as well as infectious diseases induced by HSV-1 and S. aureus. Genetic variation(s) in APLEC may influence a wide range of infectious diseases, and our data suggest that the direction of impact will be difficult to predict in a particular disease, as survival rates of DA and R17 rats were opposite in viral-induced encephalitis compared with bacterial-induced sepsis. This paradox most likely reflects the complexity of the innate and adaptive immune responses involved in the two different types of provocation. Our data that R17 rats were resistant to HSV-encephalitis when compared with DA rats extends a recent study showing that DA rats developed rapidly lethal encephalitis, whereas PVG rats were resistant after the challenge of HSV. 27 We thus provide an original example of a quantitative trait locus influencing HSV encephalitis, that is DA vs PVG genotype(s) in APLEC. Interestingly, infected R17 rats had HSV in their brains, accompanied by infiltrating macrophages and lymphocytes. There are most likely fundamental differences in the inflammatory reactions occurring in R17 and DA rats, leading to different profiles of effector functions. It would be of interest for future work to register, for example, the inflammatory cell profile and the cytokines produced, as well as the intracranial pressure in R17 and DA rats, as it was recently shown that the ability to survive HSV infection correlates with the capability to counteract increased brain pressure. 28 In the sepsis model the high mortality of R17 rats hindered a thorough clinical investigation of the septic arthritis that we aimed to investigate. Nonetheless, it is clear that R17 rats developed arthritis later than did DA rats, which is similar to observations in models of rheumatoid arthritis. 5 Altogether, our data show that APLEC is a novel determinant of pathogenesis not only in autoimmune diseases but also in infectious diseases. Further study of the impact of APLEC in different infectious disease settings is warranted.
On a mechanistic level, we show that APLEC influences cellular responses, as evidenced by both reduced monocyte-dependent DTH in vivo, and MF arginase activity in vitro in R17 compared with DA rats. Similar data were reported earlier for standard inbred rat strains, including PVG, which is the donor strain for APLEC in R17. Our data, therefore, extend a previous study of LPSinduced arginase activity reflecting reduced autoimmune susceptibility, 15 by defining a novel genetic locus, that is APLEC, which regulates this phenotype.
The gene complex also regulated transcript levels for a wide range of cytokines following stimulation with various microbial adjuvants or pathogen-associated molecular patterns. Although mRNA and protein levels do not always correlate, as exemplified here by IL-6, it is clear that APLEC regulates correlating mRNA and protein levels of IL-10, which is a suggested master regulator of immunity to viral, bacterial and protozoal infections. 29 As several of the tested microbial adjuvants are pathogenic and can, for example induce arthritis, 25 it will be interesting to investigate whether in vitro phenotypes can be used to predict in vivo phenotypes, such as disease susceptibility and disease course.
We show increased IL-10 activity in MF following stimulation with LPS, mannan and b-glucan in R17 compared with DA. However, as arginase activity was lower in R17 than DA following stimulation with LPS, the MF activation phenotypes cannot be readily classified into the simplistic 'classically' or 'alternatively' activated macrophage categories. 30 One issue that remains to be resolved is whether the APLEC gene products act as receptors for all the various microbial stimulants. Non-exclusive alternatives include that they may modulate responses to the different adjuvants in other ways, for example, through effects on the resultant intracellular signaling pathways or through binding of induced endogenous danger-associated molecular patterns. 31 Our results suggest that APLEC influences the basal expression of other innate immunity receptors, as mRNA levels for Dectin-1 and CD163 were higher in MF from R17 compared to DA, in contrast with lower mRNA levels for the APLEC genes Dcir4, Dcir1, Mcl and Mincle.
Following stimulation, the transcript levels for APLEC genes were notably dichotomous, with downregulated mRNA levels for Dcir receptors but upregulated levels for Mincle and Mcl. This may indicate a shift toward activating signaling, as rodent Dcir1-2 contain ITIMs, predicting inhibitory function, whereas rodent Dcar1 and Mincle have a charged amino acid in the transmembrane region and associate with an FcRg chain containing ITAM, predicting activating function. The relative up-or downregulation of transcript levels were generally more pronounced in R17 compared with DA MF, which may reflect that the balance between opposing signals regulates MF effector functions, similar to that described for natural killer cell receptors on natural killer cells. [32] [33] [34] Another unresolved question concerns which of the APLEC gene(s) exert an impact on innate immunity. Rat Dcar1 is a strong candidate as it appears functional in R17 rats but nonsense mutated in DA rats. 6 Interestingly, we discovered that Dcar1 mRNA expression was rapidly lost in vitro. The strikingly differential in vitro responses of DA-and R17-derived BMMF are therefore most likely not mediated by Dcar1, but rather by the other rat APLEC gene products, that is, Dcir1-4, Mcl and Mincle. Consequently, the same genes also represent strong candidate regulators for the differential in vivo phenotypes described both herein and earlier in RA models. 5, 6 Unfortunately, it will be difficult to delineate the effect of each rat gene and gene product because homologous recombination is not yet applicable in the rat.
Generation of knockout mice for each APLEC gene will be important tools for future studies. To be conclusive, however, such studies should be performed on a uniform genetic background, preferably using embryonic stem cells from the same strain that will be used for experimentation. 35 Otherwise, the deleted APLEC gene will be located in a disparate chromosomal fragment transferred between strains, thus introducing the risk of unwanted genetic variation in both APLEC and adjacent loci. There is in fact evidence that loci close to APLEC can regulate both arthritis and encephalomyelitis. 36, 37 Nonetheless, the recent report that deletion of mouse Dcir1 influences arthritis and autoimmunity, 38 combined with our similar results regarding rat APLEC 5, 6 and the association of RA with human APLEC and DCIR, 6 do point to evolutionarily conserved functions.
Importantly, we have used an experimental system, DA vs R17, which effectively identifies association between APLEC and phenotypes, and our results show that APLEC genes and their encoded receptors are of general interest in situations where it is desirable to modulate macrophage activity, including immune reactions such as DTH, as well as infectious disease development. It will clearly be important to define the nature of binding ligands, including the identification of agonists and antagonists. It is likely that such information will illuminate the hitherto limited knowledge on functions of APLEC genes and gene products, and thus provide additional possibilities of pathway manipulations.
Our data provide incitement for further studies on the rapidly growing field of APLEC genes and their encoded receptors. 5, 6, 11, [38] [39] [40] [41] [42] [43] [44] 
Materials and methods
Rat breeding and derivation
Inbred DA rats were originally obtained from Zentralinstitut fü r Versuchstierzucht (Hannover, Germany), whereas inbred PVG.1AV1 rats were originally obtained from Harlan UK Ltd (Oxon, UK). APLEC congenic rats (R17) were derived by transfer of APLEC from PVG.1AV1 onto DA background through 17 backcross generations. 5, 6 The transferred chromosomal fragment has inner borders defined by the microsatellites D4Kir151 and D4Kir 55, at positions 159.442 and 159.981, respectively, and outer borders defined by microsatellites D4Kir152 and D4Kir 59, at positions 159.384 and 160.002, respectively. The fragment contains genes encoding C-type lectin-like receptors as described earlier, 5, 6 with the following adjustments following the recent updates of the NCBI (updated 3 September 2008) and Ensembl (release 51, November 2008) rat databases. First, in NCBI, Dcir4 (159.426-436) is located on the centromeric recombination border, where the genotype is uncertain, as described earlier, 5 but there is no match for Dcir4 in Ensembl. Second, two novel genes or pseudogenes were annotated in the locus in Ensembl: RGD1559669 predicted (159.846-847), known pseudogene (6 exons, the transcript has no translation); and LOC686145 (159.960-999), that is vomeronasal 2 receptor 48, located on the telomeric recombination border. All DA and R17 rats were obtained from nuclear breeding at the Center for Molecular Medicine at Karolinska Institutet, where they were kept under specific pathogen-free conditions as determined by the National Veterinary Institute in Uppsala, Sweden, according to a health monitoring program issued by the Federation of European Laboratory Animal Science Associations (FELASA). Rats used for in vitro experiments with BMMF were housed at the Center for Molecular Medicine, whereas rats used for other experiments were housed in the animal facility of the Department of Rheumatology and Inflammation Research, University of Gö teborg. All the rats used were maintained in a climate-controlled environment with 12 h light/dark cycles, housing in polystyrene cages containing wood shavings, and had free access to standard rodent food and water ad libitum. Experiments were performed with the approval of the respective Ethical Committees of Stockholm North and Gö teborg University.
Infection with S. aureus and evaluation of arthritis
The S. aureus strain-1 was originally isolated from the joints of a spontaneously arthritic New Zealand Black/ White mouse. 45 The bacteria were cultured for 24 h on blood agar plates, replated for another 24 h, washed and kept frozen at À20 1C in phosphate-buffered saline containing 5% bovine serum albumin and 10% dimethyl sulfoxide (C 2 H 6 OS) until used. Before use, the bacterial solution was washed in phosphate-buffered saline and prepared in phosphate-buffered saline at a concentration of 5 Â 10 8 bacteria per ml. One milliliter of the solution was injected into one of the tail veins on day 0. Viable counts were used to re-check the concentration of bacteria injected. All the rats were monitored individually and their limbs were inspected visually every second day. Arthritis was defined as visible joint erythema and/ or swelling of at least one joint. To evaluate the intensity of arthritis, a clinical scoring system of 0 to 3 points for each limb was used (1 point: mild swelling and/or erythema; 2 points: moderate swelling and erythema; 3 points: marked swelling and erythema). The arthritic index was the cumulative score for all four limbs of each animal divided by the number of animals. The overall condition of each rat was evaluated by assessing its weight, general appearance and alertness.
Infection with HSV-1 and evaluation of encephalitis
The presently used encephalitogenic HSV-1 strain no. 2762 was originally isolated from a human fatal case of encephalitis. 46 The instilled solution comprised 25 ml of a 1:500 dilution in Hanks medium of a stock solution with 1.7 Â 10 7 PFU ml À1 (batch no. 011028). The rats were deeply anesthetized with isofluran, after which the infection was performed by intranasal instillation of 25 ml HSV-1. After infection had been accomplished, the animals were watched around the clock, 24 h, to immediately detect symptoms of neurological malfunction. The symptoms usually developed 5-7 days after the intranasal viral challenge, often starting with repetitive, stereotypic movements and motor instability. The animals were, however, immediately killed when definitive symptoms of neurological dysfunction were assured by two senior researchers and one skilled animal technician. The duration of all experiments was limited to 10 days.
Tissue preparation and immunohistochemistry
The brains were dissected and isolated from deeply anesthetized rats, and fixed by immersion in 4% formaldehyde in buffered saline. In some experiments, the fixation was performed by transcardial perfusion with phosphate-buffered saline followed by the mentioned fixative. Thereafter, the tissues were processed for histopathological and immunohistochemical investigations. 47 Specimens were prepared from 3 mm coronal brain slices and embedded in paraffin. Sections cut at 4 mm were prepared. After dewaxing, endogenous peroxidase activity was quenched with 3% H 2 O 2 . Antigen retrieval was performed by heating the sections in a microwave oven in a 0.01 M sodium citrate buffer, pH 6.0. After blocking unspecific binding with 0.5% blocking solution (Roche Diagnostics Scandinavia, Bromma, Sweden), the sections were incubated with a polyclonal antibody against HSV-1 (no. B0114; DakoCytomation Norden, Solna, Sweden) diluted in the blocking solution to 0.7-1.4 mg IgG per ml. Control sections were incubated with normal rabbit IgG (DakoCytomation) diluted to the same concentration. DakoCytomation EnVision þ System-HLP was used as secondary reagent and 5-bromo-4-chloro-3-indolylphosphate and 4-nitro blue tetrazolium (Roche Diagnostics) as substrate.
Parallel sections were incubated with monoclonal antibodies against ED1, CD 8 and CD3 (AbD Serotec, Oxford, UK). Endogenous peroxidase activity was quenched with 3% H 2 O 2 . Antigen retrieval, blocking and incubations with the primary antibodies were performed as described above. EnVision þ System-HRP was used as secondary reagent with 3,3 0 -diaminobenzidine and H 2 0 2 as substrates. The sections were lightly counterstained with hematoxylin, dehydrated and mounted. Further sections were stained with cresyl violet to visualize the histology.
Induction and evaluation of in vivo cell-mediated inflammatory responses
For induction of DTH, naive rats were sensitized by epicutaneous application of 450 ml of a mixture of absolute ethanol and acetone (5:4) containing 15% 4-ethoxymethylene-2-phenyloxazolone (Sigma Chemical Co., St Louis, MO, USA) on the abdomen and thorax skin. Seven days later, all mice were challenged by application of 40 ml 10% oxazolone dissolved in acetone and olive oil on both sides of the right ear. The thickness of the ear, which is a measure of antigen-specific T-cell responsiveness, was analyzed before and 24 h after oxazolone challenge, using an Oditest spring caliper (Krö plin, Schluchtern, Germany) as described earlier. 48 All challenges and measurements were performed under light anesthesia. The intensity of the DTH reaction was expressed as (ear thickness 24 h Àear thickness 0 h ) Â 10 À3 cm. For induction of inflammation by olive oil, 100 ml of olive oil (Apoteksbolaget AB, Gö teborg, Sweden) was injected intradermally (i.d) in the hind footpad. Footpad swelling was assessed 24 h later using an Oditest spring caliper. The intensity of the olive oil-induced inflammation was expressed as (footpad thickness 24 h Àfootpad thickness 0 h ) Â 10 À3 cm.
Macrophage cell culture and harvesting Bone marrow cells from rat femurs were collected by flushing through the bone cavity with medium using a 23 gauge needle. Single-cell suspensions were prepared and resuspended in Dulbecco's modified Eagle's medium (Gibco-BRL, Grand Island, NY, USA) supplemented with 20% heat-inactivated fetal calf serum, 1 mM sodium pyruvate, 100 U ml À1 penicillin, 100 mg ml À1 streptomycin, 2 mM L-glutamine, and b-mercaptoethanol (all reagents from Life Technologies, Paisley, Scotland) and 20% L929 cell line supernatant (L929 SN). Cells were cultured at 37 1C in a humidified incubator for 10 days and for a further 2 days without 20% L929 SN. Cells were detached by adding prewarmed (37 1C) 1 Â trypsin/ EDTA (Invitrogen, Lidingö , Sweden).
Microbial stimulants
All reagents were obtained from Sigma-Aldrich (Stockholm, Sweden) unless otherwise stated: zymosan, mannan and b-glucan 50 mg ml À1 ; peptidoglycan (PGN, a gift from Prof Andrej Tarkowski, University of Gö teborg, Sweden)
N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP) and CpG oligodeoxynucleotides (ODNs) (Scandinavian Gene Synthesis AB, Kö ping, Sweden) 10 mg ml
À1
. The CpG ODNs were CpG sequences with a stabilized, phosphorothioate-modified backbone, and the sequence of CpG ODNs used was 5 0 -TCCATGA CGTTCCTGATGCT-3 0 . All the above stimulants were applied to MF cultures individually. LPS 100 ng ml À1 and IFN-g 100 U ml À1 (recombinant rat IFN-g, a gift from Dr Peter van der Meide, Utrecht University, the Netherlands) were applied individually or in combinations, as indicated in results and figure legends.
Measurement of arginase activity MF were plated at 1 Â 10 6 cells ml À1 in 12-well plates (Nunc, Roskilde, Denmark) and incubated with 100 ng ml À1 LPS for 18 h. Cells were thereafter lysed with 100 ml 0.1% Triton X-100. After 30 min incubation on a shaker at room temperature, 100 ml 10 nM MnCl 2 and 100 ml 50 mM Tris-HCl (pH 7.5) were added to the sample. The arginase was then activated by heating the sample for 10 min at 56 1C, and arginine hydrolysis was conducted by incubating 100 ml of the sample with 100 ml 0.5 M L-arginine (pH 9.7) at 37 1C for 60 min. The reaction was stopped by adding 900 ml H 2 SO4 (96%)/ H 3 PO4 (85%)/H 2 O (1:3:7 v/v/v) and the sample was mixed with 40 ml 9% isonitrosopropiophenone (dissolved in 100% ethanol). After heating at 100 1C for 45 min, the product urea concentration was determined by spectrometry at 540 nm using a plate reader (LabSystems, Basingstoke, UK) and a urea standard curve. Samples were analyzed individually.
Quantification of nitrite in culture supernatants
Measurement of NO 2 À using the Griess reagent provides a surrogate marker and quantitative indicator of NO production. Supernatants from MF that had been incubated at a concentration of 1 Â 10 5 cells ml À1 with LPS (100 ng ml
À1
) and IFNg (100 U ml
) for up to 96 h were analyzed. Samples were plated in triplicate wells of 96-well plates, mixed with an equal volume of freshly prepared modified Griess reagent (Sigma-Aldrich), and incubated for 15 min at room temperature. The product NO 2 À concentration was determined by spectrometry at 540 nm using a plate reader (LabSystems) and a Sodium Nitrite standard curve. Samples were analyzed individually.
Determination of mRNA expression
BMMFs from each sample (4 Â 10 5 cells) were harvested and total RNA was extracted using an RNeasy Mini Kit (Qiagen, Stanford, CA, USA). Samples were incubated with DNase for 30 min to avoid genomic DNA contamination (Qiagen RNase-free DNase set). Reverse transcription was performed with 10 ml of total RNA, 0.1 mg ml À1 random hexamer primer (Invitrogen) and 200 U ml À1 Superscript reverse transcriptase (Invitrogen). Primers were designed using the Primer Express software (Perkin-Elmer, Wellesley, MA, USA), constructed over cDNA sequence (access from NCBI, http://www.ncbi.nlm.nih.gov/sites/entrez?db ¼ gene) exon/exon boundaries to avoid amplification of contaminating genomic DNA, and ordered from Cybergene (Stockholm, Sweden). Primer sequences used were summarized in Table 1 . Amplification and quantitative analyses were performed using iQ5 real-time PCR Detection System (Bio-Rad Laboratory, Hercules, CA, USA) and SYBR green methodology (iQ SYBR Green Supermix, Bio-Rad Laboratory). Relative quantification of mRNA levels was calculated (iQ5 Optical System Software Version 2.0, Bio-Rad Laboratory) using standard curves generated using five serial dilutions (1:1, 1:5, 1:25, 1:125, 1:625) from pooled samples. Individual samples were run in duplicate. After computing the relative amount of targets and reference genes, the final relative mRNA quantities of targets were represented as the ratio of the targets to three housekeeping genes, glyceraldehyde-3-phosphate dehydrogenase, b-actin and plasma membrane calcium ATPase 4, using the geometric mean of the relative quantities of the three reference genes as a normalization factor. Samples were analyzed individually.
Enzyme-linked immunosorbent assay cytokine determination
The enzyme-linked immunosorbent assay kits were used to measure secreted IL-1b (eBioscience, San Diego, CA, USA), IL-6 and IL-10 (Biosource, Camarillo, CA, USA) in culture supernatants according to the manufacturer's instructions. In brief, supernatants collected from MF, which had been incubated at a concentration of 4 Â 10 5 cells ml À1 with the indicated stimulants for 18h, were run in duplicate, and absorbance was measured at 450 nm. Samples were analyzed individually. CGTGAAAAGATGACCCAGATCA  AGAGGCATACAGGGACAACACA  PMCA4  GGCCTACTCTGTAAAGAAAATGAT  TGGCGTTGCCCATCGT  TNF-a  GACCCTCACACTCAGATCATC  ACGCTGGCTCAGCCACTC  IL-1b  GAAAGACGGCACACCCACC  AAACCGCTTTTCCATCTTCTTCT  IL-6  GAAAAGAGTTGTGCAATGGCAA  ATTTCTGGAAGTTTCAGATTGTTTCT  IL-10  CCCTCTGGATACAGCTGCG  GCTCCACTGCCTTGCTTTTATT  TGFb  TGAGTGGCTGTCTTTTGACGTC  CCTGTATTCCGTCTCCTTGGTT  Dcir4  CATTCGTCCGTGGAAGACAAA  TGCAGAGTCCCTGGAAGTGAA  Dcir3  AGCCAGGAAGAGCAGGATTTC  TGATCGACCCATTGCCATT  Dcir2  CACAAAAAATGTTTCACTCACAGAAGATA  AGTAAAGTAGCAGTAGGAGCCAAATGA  Dcir1  CCATAGCAAGGAAGAACAGGACTT  TGAATCCCAGAGCCCTATAAAATAA  Dcar1  TGCTCATCTGTTGGTGATCCA  TGTAAAATAACCCCAACGAGTGTCTA  Mcl  CACAAGGCTAACATGCATCCTAGA  GCAAAGTAACAGTTAGACTGGAATGCT  Mincle  TTTCACAGAGTCCCTGAGCTTCT  TCCCTCATGGTGGCACAGT  TLR2  CAGCGAGCAGGATTCCTATTG  TTGAAGGGTGGGTCAGAGTTCT  TLR4 CGCTCTGGCATCATCTTCAT CTCCTCAGGTCAAAGTTGTTGC Dectin-1 TCTCGTTGGCGGTCCATT AGCACTGCTGCGACCACTACT CD163 TGTAGTTCATCATCTTCGGTCCAA CCAAGCGGAGTTGACCACTT Abbreviations: GAPDH, glyceraldehyde-3-phosphate dehydrogenase; IL, interleukin; PMCA4, plasma membrane calcium ATPase 4; TGFb, transforming growth factorb; TNF-a, tumor necrosis factor-a.
Statistical methods
